Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /GSAC
chevron_leftBack
GelStat Corp. logo

GelStat Corp.

GSAC
OTCMKTS: GSAC Delayed
0.0004USD 0%
As of 13 June 2026, GelStat Corp. has a market cap of $1.5M USD, ranking #47779 globally and #6099 in the United States. It ranks #4237 in the Healthcare sector, and #331 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
47779
Country Rank
6099
Sector Rank
4237
Industry Rank
331
Key Stats
Market Cap
$1.5MUSD
Enterprise Value
$2.27MUSD
Revenue (TTM)
$363.53KUSD
EBITDA (TTM)
-$168.89KUSD
Net Income (TTM)
-$283.4KUSD
EBITDA Margin
-46%
Profit Margin
-78%
PS Ratio
4.1
PB Ratio
-1.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Javier Acosta open_in_new
Employees
2
Founded
2002
Website
gelstat.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 0% 33% 33% -14% -40%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
GSAC
GelStat Corp
ISIN: US3685331056
Shares Out.:
3.74B1 Shares Float: 3.209B2
TV:
SA:
YF:
GF:
BA:
MS:
0.0004 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About GelStat Corp.

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)
Name
Market Cap diff.
PE
$29.56B
2M%
-
INDV
$2.07B
1.54B GBP
138K%
-
NDOI
$1.8B
120K%
0.4
$1.76B
118K%
-
$1.33B
89K%
-
$1.02B
68K%
12.1
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$36.75B
108.92B ILS
2M%
24.2
$15.84B
107.34B CNY
1M%
16.0
CIPLA
$11.16B
1.06T INR
746K%
23.4
LUPIN
$11.04B
1.05T INR
738K%
22.7
$9.09B
61.6B CNY
607K%
80.6
$8.74B
7.57B EUR
584K%
-
chevron_leftBack